High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer

João Lobo, Rui Henrique, Inês Graça et al.|Urologic Oncology Seminars and Original Investigations|2017

Cited by 52